---
category: news
title: "AI program yields multiple novel RSV drug targets"
excerpt: "Poolbeg Pharma says it has made a breakthrough in its AI program with partner OneThree Biotech for the treatment of RSV."
publishedDateTime: 2022-11-08T09:11:00Z
originalUrl: "https://www.labiotech.eu/trends-news/ai-program-yields-multiple-novel-rsv-drug-targets/"
webUrl: "https://www.labiotech.eu/trends-news/ai-program-yields-multiple-novel-rsv-drug-targets/"
type: article
quality: 37
heat: 37
published: false

provider:
  name: labiotech
  domain: labiotech.eu

topics:
  - AI

images:
  - url: "https://www.labiotech.eu/wp-content/uploads/2022/11/shutterstock-1197138601.jpg"
    width: 1000
    height: 667
    isCached: true

related:
  - title: "Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets"
    excerpt: "First time AI has been used to identify disease targets in RSVLONDON, UK / ACCESSWIRE / / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ('Poolbeg' or the 'Company'), a clinical stage infectious disease"
    publishedDateTime: 2022-11-08T06:00:00Z
    webUrl: "https://www.benzinga.com/pressreleases/22/11/ac29607588/poolbeg-pharma-plc-announces-ai-programme-yields-novel-rsv-drug-targets"
    ampWebUrl: "https://www.benzinga.com/amp/content/29607588"
    cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/29607588"
    type: article
    provider:
      name: Benzinga.com
      domain: benzinga.com
    quality: 37

secured: "PJHMVwS5R0qgsa9QrbbsnPiJlXTZg4hAXccdbpCTLcnZ6TfHZmzL1/tdS9drxYhfr001CJKjDCsFIksjftqMu1p6IjBBw+bTzmmlo++coNAZcdY2F8Nao8zTl6eDRh+stokfQovU2JgtbV9P/3PKYPgsectMBSaBYpEW0cSuOQ+Vi+HnZv5pz90yt0leE78R2HhnHnlRphUHaCgr43odfmJy9Uv0iEMFTGyq0QiDxAg6lS1QBfCFVq80gZMtd/eoRmam9jRHZiglgIpdodvVuKvJUSWYCu1fHgA07kaY+XoFVBFEgulkBDul/MQer1oCGITTxigdlUsMURMNzqlPFCrmBTVEjPUMe8hfomPbVPc=;hKUImMirDYH6znvTTxWT8w=="
---

